Global Farnesene Market Size, Share, Growth Analysis, By Type(Beta Farnesene and Alpha Farnesene), By Technology(Biological and Chemical) - Industry Forecast 2024-2031


Report ID: SQMIG15A2272 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 59 | Figures: 75

To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Farnesene Market size was reported at USD 43.98 billion in 2021 and is poised to grow from USD 46 billion in 2022 to USD 65.92 billion by 2030, at a CAGR of 4.6% during the forecast period (2023-2030).

The global farnesene market is characterized by a competitive landscape with several players vying for market share. The market is witnessing the entry of new players as well as the presence of established companies, fostering intense competition. The key players in the farnesene market are engaged in strategic initiatives such as collaborations, partnerships, mergers, and acquisitions to strengthen their market position and expand their product portfolios. These companies are investing in research and development activities to improve the production processes and enhance the quality of farnesene. Additionally, players are focusing on sustainable and eco-friendly practices, aligning their business strategies with the growing demand for bio-based alternatives. The competitive landscape of the farnesene market is expected to witness further developments as companies strive to innovate and differentiate their products to cater to diverse industry requirements and gain a competitive edge. 'Amyris, Inc. - US', 'TotalEnergies - France', 'Genomatica, Inc. - US', 'Braskem - Brazil', 'GFBiochemicals Ltd. - UK', 'Arzeda - US', 'Solazyme, Inc. (now known as TerraVia Holdings) - US', 'Lavergne Group - Canada', 'Jeneil Biotech - US', 'Intrexon Corporation - US', 'ZEAChem Inc. - US', 'Global Bioenergies - France', 'LanzaTech - US', 'Verdezyne - US', 'BioAmber Inc. - Canada', 'Heliae Development, LLC - US', 'Yifan Pharmaceutical Co., Ltd. - China', 'Kapa Biosystems - US', 'Rennovia Inc. - US', 'IGZOMER - Italy'

Supportive regulations and policies aimed at promoting the use of bio-based products and reducing carbon emissions are driving the demand for farnesene. Government initiatives, incentives, and mandates encourage the adoption of renewable resources, creating a favorable market environment for farnesene.

Diversification of End-use Industries: Farnesene is finding applications in a wide range of industries beyond its traditional uses in flavors, fragrances, and polymers. It is being explored in sectors such as cosmetics, lubricants, and specialty chemicals. This diversification of end-use industries is expanding the market potential for farnesene and creating new growth opportunities.

North America is the dominating region in the global farnesene market. The North America region has a well-established industry with prominent key players in the farnesene sector. The United States has witnessed significant growth in the market due to the presence of major manufacturers and increasing investments in biological products. Various industries related to flavors, fragrances, polymers and cosmetics are driving the market in North America.

Feedback From Our Clients

Global Farnesene Market

Product ID: SQMIG15A2272

$5,300
BUY NOW